Aug 2020 $15 M No. 7 $10 to $50 million 59
AZTherapies, INC: Raise no. 7, Aug 2020 × Investors in this round 59 investors had bought by the notice of Sep 15, 2020: 59 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $15 M of $35 M offered; $20 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Brian Bartlett · Executive Officer David Elmaleh · Executive Officer, Director Karen Reeves · Executive Officer David Taft · Director George Behrakis · Director Gillian Sandler · Director Keith Greenfield · Director Noah Gottdiener · Director Peter Conti · Director Thierry Porte · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Brian Bartlett, Cfo. Source: SEC Form D, newest notice filed Sep 15, 2020. Read the notice at the SEC .
equity SEC Jun 2019 $19 M No. 6 $10 to $50 million 25
AZTherapies, INC: Raise no. 6, Jun 2019 × Investors in this round 25 investors had bought by the notice of Jul 12, 2019: 25 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $19 M of $38 M offered; $18 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Brian T. Bartlett · Executive Officer David R.. Elmaleh · Executive Officer, Director Jay T. Mohr · Executive Officer Karen T. Reeves · Executive Officer Robert S. Warren · Executive Officer David S. Taft · Director George T. Behrakis · Director Gillian T. Sandler · Director Keith S. Greenfield · Director Peter S. Conti · Director Ronald S. Tompkins · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Amount sold includes the conversion of $6,415,174 of convertible notes in the equity issued in the transaction.”Signed by David Elmaleh, Chairman. Source: SEC Form D, newest notice filed Jul 12, 2019. Read the notice at the SEC .
equity SEC May 2019 $6 M No. 5 $2 to $10 million 11
AZTherapies, INC: Raise no. 5, May 2019 × Investors in this round 11 investors had bought by the notice of May 31, 2019: 11 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $8 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David R. Elmaleh · Executive Officer, Director Karen S. Reeves · Executive Officer Keith S. Greenfield · Executive Officer, Director Robert S. Warren · Executive Officer David S. Taft · Director Gillian S. Sandler · Director John S. Porter · Director Peter S. Conti · Director Ronald S. Tompkins · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “No payments have been proposed other than payments of salaries in the ordinary course of business.”Signed by David R. Elmaleh, Ph.D., Chief Executive Officer. Source: SEC Form D, newest notice filed May 31, 2019. Read the notice at the SEC .
debt, options SEC Jun 2018 $16 M No. 4 $10 to $50 million 35
AZTherapies, INC: Raise no. 4, Jun 2018 × Investors in this round 35 investors had bought by the notice of Oct 16, 2018: 35 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $16 M of $25 M offered; $9 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David R. Elmaleh · Executive Officer, Director Karen S. Reeves · Executive Officer Keith S. Greenfield · Executive Officer, Director Robert S. Warren · Executive Officer David S. Taft · Director Gillian S. Sandler · Director John S. Porter · Director Peter S. Conti · Director Ronald S. Tompkins · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Amount offered and sold does not include the conversion of Convertible Promissory Notes in connection with the Initial Closing of the Financing.”On the use of proceeds: “No payments have been proposed other than payments of salaries in the ordinary course of business.”Signed by David R. Elmaleh, Ph.D., Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Oct 16, 2018. Read the notice at the SEC .
equity, options SEC Dec 2017 $2 M No. 3 Under $2 million 9
AZTherapies, INC: Raise no. 3, Dec 2017 × Investors in this round 9 investors had bought by the notice of Dec 18, 2017: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $6 M offered; $4 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David R. Elmaleh · Executive Officer, Director Keith S. Greenfield · Executive Officer, Director Robert S. Warren · Executive Officer David S. Taft · Director John S. Porter · Director Peter S. Conti · Director Ronald S. Tompkins · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “No payments have been proposed other than payments of salaries in the ordinary course of business.”Signed by David Elmaleh, Chairman and CEO. Source: SEC Form D, newest notice filed Dec 18, 2017. Read the notice at the SEC .
debt, options SEC Nov 2015 $16 M No. 2 $10 to $50 million 41
AZTherapies, INC: Raise no. 2, Nov 2015 × Investors in this round 41 investors had bought by the notice of Feb 6, 2017: 41 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $16 M of $20 M offered; $4 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue No revenue
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David R. Elmaleh · Executive Officer, Director Keith S. Greenfield · Executive Officer, Director Robert S. Warren · Executive Officer David S. Taft · Director John S. Porter · Director Peter S. Conti · Director Ronald S. Tompkins · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “No payments have been proposed other than payments of salaries in the ordinary course of business.”Signed by Oded Kadosh, Secretary. Source: SEC Form D and 1 amendment, newest notice filed Feb 6, 2017. Read the notice at the SEC .
equity, options SEC Dec 2014 $6 M No. 1 $2 to $10 million 15
AZTherapies, INC: Raise no. 1, Dec 2014 × Investors in this round 15 investors had bought by the notice of Jan 6, 2015: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $13 M offered; $7 M still to sell
Smallest investment taken $25,000
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions none
Finders' fees none
Paid to its own people $150,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice David R Elmaleh · Executive Officer, Director John R Porter · Director Keith R Greenfield · Director Peter R Conti · Director Ronald R Tompkins · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Oded Kadosh, Secretary. Source: SEC Form D, newest notice filed Jan 6, 2015. Read the notice at the SEC .
equity SEC